| Red cells, hemoglobin, heme, iron, and atherogenesis E Nagy, JW Eaton, V Jeney, MP Soares, Z Varga, Z Galajda, ... Arteriosclerosis, thrombosis, and vascular biology 30 (7), 1347-1353, 2010 | 253 | 2010 |
| Microbiome—microbial metabolome—cancer cell interactions in breast cancer—familiar, but unexplored E Mikó, T Kovács, É Sebő, J Tóth, T Csonka, G Ujlaki, A Sipos, J Szabó, ... Cells 8 (4), 293, 2019 | 152 | 2019 |
| Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness E Mikó, A Vida, T Kovács, G Ujlaki, G Trencsényi, J Márton, Z Sári, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1859 (9), 958-974, 2018 | 146 | 2018 |
| Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors T Kovács, E Mikó, A Vida, É Sebő, J Toth, T Csonka, A Boratkó, G Ujlaki, ... Scientific reports 9 (1), 1300, 2019 | 142 | 2019 |
| The age and genomic integrity of neurons after cortical stroke in humans HB Huttner, O Bergmann, M Salehpour, A Rácz, J Tatarishvili, E Lindgren, ... Nature neuroscience 17 (6), 801-803, 2014 | 136 | 2014 |
| Lithocholic acid, a metabolite of the microbiome, increases oxidative stress in breast cancer P Kovács, T Csonka, T Kovács, Z Sári, G Ujlaki, A Sipos, Z Karányi, ... Cancers 11 (9), 1255, 2019 | 79 | 2019 |
| Indolepropionic acid, a metabolite of the microbiome, has cytostatic properties in breast cancer by activating AHR and PXR receptors and inducing oxidative stress Z Sári, E Mikó, T Kovács, L Jankó, T Csonka, G Lente, É Sebő, J Tóth, ... Cancers 12 (9), 2411, 2020 | 77 | 2020 |
| Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence T Csonka, B Murnyák, R Szepesi, J Bencze, L Bognár, Á Klekner, ... Folia Neuropathologica 54 (2), 114-126, 2016 | 34 | 2016 |
| Poly (ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas T Csonka, B Murnyák, R Szepesi, A Kurucz, Á Klekner, T Hortobágyi Folia Neuropathologica 52 (2), 111-120, 2014 | 28 | 2014 |
| Occurrence and molecular pathology of high grade gliomas B Murnyák, T Csonka, K Hegyi, G Méhes, A Klekner, T Hortobágyi Ideggyogyaszati Szemle 66 (9-10), 312-321, 2013 | 17* | 2013 |
| Primary angiosarcoma of the pancreas mimicking severe acute pancreatitis–case report A Csiszkó, I László, K Palatka, KG Szabó, Z Kanyári, L Bidiga, T Csonka, ... Pancreatology 15 (1), 84-87, 2015 | 16 | 2015 |
| The diagnosis of herpes encephalitis--a case-based update T Csonka, R Szepesi, L Bidiga, M Péter, A Klekner, G Hutóczky, L Csiba, ... Ideggyogyaszati Szemle 66 (9-10), 337-342, 2013 | 13 | 2013 |
| Fecal expression of Escherichia coli lysine decarboxylase (LdcC) is downregulated in E-cadherin negative lobular breast carcinoma Z Sári, T Kovács, T Csonka, M Török, É Sebő, J Tóth, D Tóth, E Mikó, ... Physiology International 107 (2), 349-358, 2020 | 11 | 2020 |
| Molecular pathology of meningiomas B Murnyak, T Csonka, T Hortobagyi Ideggyogyaszati Szemle 68 (9-10), 292-300, 2015 | 11 | 2015 |
| Occurrence and molecular pathology of low grade gliomas B Murnyák, T Csonka, A Klekner, T Hortobágyi Ideggyogyaszati Szemle 66 (9-10), 305-311, 2013 | 7 | 2013 |
| Primary uterine NK-cell lymphoma, nasal-type: a unique malignancy of a prominent cell type of the endometrium G Méhes, K Hegyi, T Csonka, F Fazakas, Z Kocsis, G Radványi, I Vadnay, ... Pathology & Oncology Research 18, 519-522, 2012 | 7 | 2012 |
| Inclusion body myositis–pathomechanism and lessons from genetics B Murnyák, L Bodoki, M Vincze, Z Griger, T Csonka, R Szepesi, A Kurucz, ... Open Medicine 10 (1), 2015 | 6 | 2015 |
| Inclusion body myositis L Bodoki, M Vincze, Z Griger, T Csonka, K Dankó, T Hortobágyi Ideggyogyaszati Szemle 68 (1-2), 59-67, 2015 | 5 | 2015 |
| Anti-signal recognition particle autoantibody positive myopathy L Bodoki, M Vincze, T Hortobágyi, Z Griger, T Csonka, K Danko Ideggyogyaszati Szemle 67 (9-10), 347-353, 2014 | 4 | 2014 |
| The role of carbonic anhydrase IX in the progression of malignant tumors-a potential therapeutic target? O Matolay, SE Bádon, L Balázs, P Juhász, T Csonka, G Méhes Magyar Onkologia 65 (2), 157-166, 2021 | 3 | 2021 |
